DE69209051D1 - Verwendung von il-4 zur verstärkung von wundheilung und besserung und zur heilung von infizierten wunden und wunden bei diabetischen säugetieren - Google Patents
Verwendung von il-4 zur verstärkung von wundheilung und besserung und zur heilung von infizierten wunden und wunden bei diabetischen säugetierenInfo
- Publication number
- DE69209051D1 DE69209051D1 DE69209051T DE69209051T DE69209051D1 DE 69209051 D1 DE69209051 D1 DE 69209051D1 DE 69209051 T DE69209051 T DE 69209051T DE 69209051 T DE69209051 T DE 69209051T DE 69209051 D1 DE69209051 D1 DE 69209051D1
- Authority
- DE
- Germany
- Prior art keywords
- wounds
- healing
- enhancing
- enhance
- improving
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 206010052428 Wound Diseases 0.000 title abstract 8
- 208000027418 Wounds and injury Diseases 0.000 title abstract 8
- 241000124008 Mammalia Species 0.000 title abstract 4
- 108090000978 Interleukin-4 Proteins 0.000 title abstract 3
- 230000035876 healing Effects 0.000 title abstract 3
- 206010012601 diabetes mellitus Diseases 0.000 title abstract 2
- 230000002708 enhancing effect Effects 0.000 abstract 4
- 206010061598 Immunodeficiency Diseases 0.000 abstract 1
- 239000000512 collagen gel Substances 0.000 abstract 1
- 230000029663 wound healing Effects 0.000 abstract 1
- 230000037314 wound repair Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/20—Interleukins [IL]
- A61K38/2026—IL-4
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Epidemiology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US63963191A | 1991-01-10 | 1991-01-10 | |
| PCT/US1992/000024 WO1992011861A1 (en) | 1991-01-10 | 1992-01-07 | Use of il-4 to enhance the reparative phase of wound healing and repair and to enhance the healing of infected wounds and the wounds of diabetic mammals |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| DE69209051D1 true DE69209051D1 (de) | 1996-04-18 |
| DE69209051T2 DE69209051T2 (de) | 1996-08-08 |
Family
ID=24564917
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE69209051T Expired - Fee Related DE69209051T2 (de) | 1991-01-10 | 1992-01-07 | Verwendung von il-4 zur verstärkung von wundheilung und besserung und zur heilung von infizierten wunden und wunden bei diabetischen säugetieren |
Country Status (11)
| Country | Link |
|---|---|
| EP (2) | EP0566661B1 (de) |
| JP (1) | JPH0747545B2 (de) |
| AT (1) | ATE135233T1 (de) |
| AU (1) | AU660959B2 (de) |
| CA (1) | CA2099263C (de) |
| DE (1) | DE69209051T2 (de) |
| DK (1) | DK0566661T3 (de) |
| ES (1) | ES2085003T3 (de) |
| GR (1) | GR3019708T3 (de) |
| IE (1) | IE75707B1 (de) |
| WO (1) | WO1992011861A1 (de) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5206345A (en) * | 1990-08-02 | 1993-04-27 | Fred Hutchinson Cancer Research Center | Il-4 and tnf induce mab 6g10-recognized expression on bone marrow stromal cells |
| AU696560B2 (en) * | 1993-03-19 | 1998-09-10 | Fred D. Finkelman | Pharmaceutical compositions comprising a ligand complexed with a soluble receptor |
| GB2304047A (en) | 1995-08-09 | 1997-03-12 | Univ Manchester | Pharmaceutical compositions containing cytokines |
| GB2430031A (en) * | 2005-09-07 | 2007-03-14 | Ethicon Inc | Diagnostic markers of wound infection |
| EP4422668A1 (de) * | 2021-10-25 | 2024-09-04 | Ellennbe GmbH | Pharmazeutische zusammensetzung und kit mit einer immunmodulatorischen substanz zur behandlung von krankheiten |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PT83761B (pt) * | 1985-11-19 | 1989-06-30 | Schering Biotech Corp | Metodo para a producao de interleuquina-4 de mamifero |
| DE3882611T2 (de) * | 1987-08-03 | 1993-12-23 | Tasuku Honjo | Menschliches Interleukin-4, Expressionsvektoren dafür und diese enthaltende Transformanten. |
| WO1990007932A1 (en) * | 1989-01-20 | 1990-07-26 | The University Of Melbourne | Fibrinolysis |
| KR100191223B1 (ko) * | 1989-07-28 | 1999-06-15 | 둘락 노먼 씨. | 인터루킨-4의 정제방법 및 이를 함유하는 약제학적 조성물 |
| HUT63062A (en) * | 1990-03-21 | 1993-07-28 | Schering Corp | Process for producing pharmaceutical compositions increasing the immune response and comprising il-4 |
-
1992
- 1992-01-07 DK DK92904122.6T patent/DK0566661T3/da active
- 1992-01-07 AT AT92904122T patent/ATE135233T1/de not_active IP Right Cessation
- 1992-01-07 ES ES92904122T patent/ES2085003T3/es not_active Expired - Lifetime
- 1992-01-07 JP JP4504436A patent/JPH0747545B2/ja not_active Expired - Lifetime
- 1992-01-07 AU AU11980/92A patent/AU660959B2/en not_active Ceased
- 1992-01-07 DE DE69209051T patent/DE69209051T2/de not_active Expired - Fee Related
- 1992-01-07 WO PCT/US1992/000024 patent/WO1992011861A1/en active IP Right Grant
- 1992-01-07 EP EP92904122A patent/EP0566661B1/de not_active Expired - Lifetime
- 1992-01-07 CA CA002099263A patent/CA2099263C/en not_active Expired - Fee Related
- 1992-01-09 IE IE920070A patent/IE75707B1/en not_active IP Right Cessation
- 1992-01-10 EP EP92300231A patent/EP0502599B1/de not_active Expired - Lifetime
-
1996
- 1996-04-22 GR GR960401091T patent/GR3019708T3/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| ES2085003T3 (es) | 1996-05-16 |
| GR3019708T3 (en) | 1996-07-31 |
| EP0566661A1 (de) | 1993-10-27 |
| CA2099263A1 (en) | 1992-07-11 |
| EP0502599B1 (de) | 1996-03-13 |
| WO1992011861A1 (en) | 1992-07-23 |
| AU1198092A (en) | 1992-08-17 |
| JPH05509333A (ja) | 1993-12-22 |
| JPH0747545B2 (ja) | 1995-05-24 |
| ATE135233T1 (de) | 1996-03-15 |
| CA2099263C (en) | 1997-03-11 |
| DK0566661T3 (da) | 1996-07-01 |
| DE69209051T2 (de) | 1996-08-08 |
| AU660959B2 (en) | 1995-07-13 |
| EP0502599A1 (de) | 1992-09-09 |
| EP0566661B1 (de) | 1996-03-13 |
| IE75707B1 (en) | 1997-09-10 |
| IE920070A1 (en) | 1992-07-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE109352T1 (de) | Heilung von wunden. | |
| DE3785758D1 (de) | Wundheilung und knochenregeneration. | |
| ATE82507T1 (de) | Medizinische verwendung. | |
| DE69935522D1 (de) | Kosmetische oder dermopharmazeutische verwendung von peptiden zur wundheilung, hydratisierung, verbesserung des hautaussehens während der natürlichen oder beschleunigten alterung (heliodermie, pollution) | |
| FI924778A7 (fi) | GM-CSF:n ja G-CSF:n käyttö haavojen paranemisen nopeuttamiseksi | |
| ATE234921T1 (de) | Osteoinduktive zusammensetzungen | |
| DE69131847D1 (de) | Verwendung von kupfer enthaltenden wirkstoffen zur beschleunigung der wundheilung | |
| NO894643D0 (no) | Sammensatt kompresjons- og stoettebandasje. | |
| ATE229814T1 (de) | Verwendung von il-10 zur wundheilung mit verminderter narbenbildung | |
| DE69231486D1 (de) | Zusammensetzung enthaltend pdgf und dexamethason zur förderung von gewebsreparatur und -regenerierung | |
| ATE228004T1 (de) | Verwendung von relaxin zur stimulierung der angiogenese | |
| ATE120206T1 (de) | Peptide, die die bindung des von-willebrand- faktors inhibieren. | |
| ATE156363T1 (de) | Wundheilung | |
| DE68905342D1 (de) | Verwendung von minoxidil zur wundheilung. | |
| ATE173401T1 (de) | Neue verwendung von 1-alpha-hydroxylierten-19-nor-vitamin-d-verbind ngen zur behandlung von psoriasis | |
| DE69209051D1 (de) | Verwendung von il-4 zur verstärkung von wundheilung und besserung und zur heilung von infizierten wunden und wunden bei diabetischen säugetieren | |
| ATE93721T1 (de) | Verwendung von fluoxetin zur behandlung des diabetes. | |
| ATE227995T1 (de) | Verwendung von pseudopterosin zur förderung der wundheilung | |
| DE69732616D1 (de) | Erhöhung der Migration oder Proliferation von Keratinocyten | |
| DE3884895D1 (de) | Verwendung von Bezafibrat zur Behandlung von Diabetes. | |
| ATE181082T1 (de) | Fibroblastwachstumsfaktor und ascorbinsäure enthaltende wundheilungszusammensetzungen | |
| DE69231916D1 (de) | Makroskopisch orientiertes zelladhäsionsprotein zur wundbehandlung | |
| DE69528573D1 (de) | Verwendung einer Zubereitung enthaltend einen Plasminogen-Aktivator für die Verbesserung der Wundheilung | |
| DE69723725D1 (de) | Verfahren zur herstellung von konzentrierten lösungen von fibronectin ohne puffer | |
| ATA4993A (de) | Topische zusammensetzung zur beschleunigung der wundheilung |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 8364 | No opposition during term of opposition | ||
| 8339 | Ceased/non-payment of the annual fee |